ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
5.04
-0.07 (-1.37%)
At close: Nov 20, 2024, 4:00 PM
5.00
-0.04 (-0.79%)
After-hours: Nov 20, 2024, 4:42 PM EST
ReShape Lifesciences Employees
ReShape Lifesciences had 29 employees as of December 31, 2023. The number of employees decreased by 11 or -27.50% compared to the previous year.
Employees
29
Change (1Y)
-11
Growth (1Y)
-27.50%
Revenue / Employee
$282,172
Profits / Employee
-$243,690
Market Cap
2.55M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Fresh2 Group | 75 |
Avinger | 72 |
Molecular Templates | 62 |
Nuwellis | 59 |
Scinai Immunotherapeutics | 31 |
ENDRA Life Sciences | 21 |
Petros Pharmaceuticals | 21 |
HeartSciences | 15 |
RSLS News
- 6 days ago - ReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update - GlobeNewsWire
- 8 days ago - ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX - GlobeNewsWire
- 9 days ago - ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape's Proprietary Diabetes Bloc-Stim Neuromodulation™ Technology - GlobeNewsWire
- 2 months ago - ReShape Lifesciences Announces 1-for-58 Reverse Stock Split - GlobeNewsWire
- 3 months ago - ReShape Lifesciences Inc. (RSLS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update - GlobeNewsWire
- 4 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of Shareholders - GlobeNewsWire